Tanana Chiefs Conference
Tanana Chiefs Conference was paid $107.48M by Medicaid between Jan 2018 and Dec 2024, across 133 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 47% of everything it billed.
33Billing provider infoTANANA CHIEFS CONFERENCE
FAIRBANKS, AK 99701
FAIRBANKS, AK 99701
33aNPI1821201278assigned 05/08/2007
33bProvider typeChore Provider
28Total paid$107.48M
24GClaims280,266
24DCodes billed133
24AFirst – last monthJan 2018 – Dec 2024
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official BERGSTROM, JACOLINE controls 14+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 29,458 | $8.86M | |
| 2019 | 38,854 | $12.97M | |
| 2020 | 32,151 | $11.82M | |
| 2021 | 48,829 | $19.20M | |
| 2022 | 50,455 | $19.09M | |
| 2023 | 46,260 | $17.63M | |
| 2024incomplete | 34,259 | $17.92M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 47% | 89,623 | 79,604 | $50.04M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 22% | 44,250 | 38,853 | $23.30M |
| 92340 | Fitting of spectacles, except for aphakia; monofocal | 5.1% | 8,173 | 7,453 | $5.47M |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 5.1% | 8,842 | 8,079 | $5.46M |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 2.3% | 4,686 | 4,186 | $2.49M |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 2.1% | 5,195 | 2,840 | $2.23M |
| 99442 | 1.6% | 3,094 | 2,521 | $1.72M | |
| 99443 | 1.6% | 2,686 | 2,049 | $1.70M | |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 1.4% | 2,109 | 1,986 | $1.51M |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 1.4% | 6,178 | 5,654 | $1.49M |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 1,526 | 1,452 | $1.07M |
| 0002A | <1% | 1,714 | 1,592 | $976K |
121 more codes
| 0001A | <1% | 1,675 | $873K | |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | <1% | 3,054 | $847K |
| 99441 | <1% | 1,249 | $670K | |
| 80053 | Comprehensive metabolic panel | <1% | 5,902 | $655K |
| 92012 | Ophthalmological services: medical examination and evaluation, intermediate, established patient | <1% | 1,654 | $585K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 4,189 | $527K |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | <1% | 1,532 | $454K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 3,410 | $418K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 698 | $369K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 486 | $343K |
| 0011A | <1% | 438 | $310K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 4,314 | $307K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 353 | $248K |
| 0012A | <1% | 405 | $246K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 20,855 | $210K |
| 0004A | <1% | 557 | $186K | |
| 0072A | <1% | 201 | $176K | |
| 97161 | <1% | 279 | $170K | |
| 0071A | <1% | 268 | $160K | |
| 92002 | <1% | 392 | $160K | |
| 81001 | <1% | 1,455 | $152K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 2,304 | $145K |
| 92341 | <1% | 218 | $128K | |
| 92015 | Determination of refractive state | <1% | 10,001 | $123K |
| 0003A | <1% | 226 | $114K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 679 | $114K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 1,133 | $100K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 132 | $87K |
| 85018 | <1% | 660 | $86K | |
| 90686 | <1% | 482 | $82K | |
| 98928 | <1% | 560 | $82K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 130 | $76K |
| 90480 | <1% | 334 | $68K | |
| 0031A | <1% | 108 | $65K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 147 | $56K |
| 87480 | <1% | 1,410 | $56K | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 85 | $46K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 547 | $44K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 71 | $43K |
| 0124A | <1% | 99 | $43K | |
| 0054A | <1% | 63 | $39K | |
| 87631 | <1% | 324 | $31K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 424 | $28K |
| 80061 | Lipid panel | <1% | 369 | $25K |
| 98968 | <1% | 50 | $25K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 452 | $24K |
| 85027 | <1% | 231 | $20K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 78 | $17K |
| 90674 | <1% | 125 | $15K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 344 | $14K |
| 90461 | <1% | 2,130 | $13K | |
| 81025 | <1% | 366 | $12K | |
| 0074A | <1% | 14 | $11K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 32 | $11K |
| 0064A | <1% | 12 | $10K | |
| 90792 | Psychiatric diagnostic evaluation with medical services | <1% | 30 | $9K |
| 86580 | <1% | 13 | $9K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 51 | $8K |
| 80306 | <1% | 21 | $7K | |
| 86803 | <1% | 107 | $7K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 13 | $6K |
| 82950 | <1% | 12 | $6K | |
| 98967 | <1% | 15 | $6K | |
| 98940 | <1% | 184 | $6K | |
| 83540 | <1% | 202 | $5K | |
| 82607 | <1% | 104 | $4K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 12 | $4K |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 1,087 | $4K |
| 20610 | <1% | 234 | $4K | |
| 98941 | Chiropractic manipulative treatment; spinal, 3-4 regions | <1% | 390 | $4K |
| 81003 | <1% | 95 | $3K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 16 | $3K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 2,327 | $3K |
| 0154A | <1% | 15 | $3K | |
| 96127 | <1% | 674 | $3K | |
| 73630 | <1% | 14 | $2K | |
| 87660 | <1% | 1,400 | $2K | |
| 96380 | <1% | 16 | $1K | |
| 86704 | <1% | 41 | $808.00 | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 178 | $710.00 |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 13 | $682.00 |
| G0108 | Diabetes outpatient self-management training services, individual, per 30 minutes | <1% | 36 | $235.53 |
| G0127 | Trimming of dystrophic nails, any number | <1% | 13 | $70.56 |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 131 | $58.87 |
| 92134 | <1% | 18 | $38.55 | |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | <1% | 25 | $32.42 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 17 | $11.78 |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 16 | $7.39 |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 31 | $6.51 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 86 | $0.68 |
| 87510 | 0% | 1,409 | $0.00 | |
| 36416 | 0% | 590 | $0.00 | |
| 86780 | 0% | 118 | $0.00 | |
| 82728 | 0% | 161 | $0.00 | |
| T1016 | Case management, each 15 minutes | 0% | 5,396 | $0.00 |
| 77063 | Screening digital breast tomosynthesis, bilateral | 0% | 130 | $0.00 |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 0% | 25 | $0.00 |
| 83986 | 0% | 12 | $0.00 | |
| 90656 | 0% | 48 | $0.00 | |
| 90381 | 0% | 15 | $0.00 | |
| 87340 | 0% | 13 | $0.00 | |
| 90474 | 0% | 62 | $0.00 | |
| 90834 | Psychotherapy session, about 45 minutes | 0% | 45 | $0.00 |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | 0% | 14 | $0.00 |
| 87088 | 0% | 14 | $0.00 | |
| 86769 | 0% | 70 | $0.00 | |
| 86592 | 0% | 18 | $0.00 | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 0% | 12 | $0.00 |
| H2021 | Community-based wrap-around services, per 15 minutes | 0% | 6,434 | $0.00 |
| 98926 | 0% | 14 | $0.00 | |
| 91322 | 0% | 122 | $0.00 | |
| 90837 | Psychotherapy session, about an hour | 0% | 1,021 | $0.00 |
| H2015 | Community support for mental illness or disability, per 15 minutes | 0% | 602 | $0.00 |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 0% | 22 | $0.00 |
| 84466 | 0% | 173 | $0.00 | |
| 99408 | 0% | 71 | $0.00 | |
| 99173 | 0% | 126 | $0.00 | |
| 98960 | 0% | 15 | $0.00 | |
| J7030 | Infusion, normal saline solution , 1000 cc | 0% | 28 | $0.00 |
| T1007 | Alcohol and/or substance abuse services, treatment plan development and/or modification | 0% | 45 | $0.00 |
| 90670 | 0% | 22 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialBERGSTROM, JACOLINE (DIRECTOR OF HEALTH SERVICES)
| Provider | Location | Paid |
|---|---|---|
| Tanana Chiefs Confenerce | Fairbanks, AK | $24.06M |
| Tanana Chiefs Conference | Fairbanks, AK | $17.04M |
| Tanana Chiefs Conference | Fairbanks, AK | $16.34M |
| Tanana Chiefs Conference | Fairbanks, AK | $14.17M |
| Tanana Chiefs Conference | Fairbanks, AK | $9.33M |
| Tanana Chiefs Conference | Fairbanks, AK | $1.48M |
| Tanana Chiefs Conference | Fairbanks, AK | $676K |
| Tanana Chiefs Conference | Fairbanks, AK | $451K |
| Tanana Chiefs Conference | Fairbanks, AK | $157K |
| Tanana Chiefs Confenerce | Fairbanks, AK | $45K |
| Chief Andrew Issac Health Center | Fairbanks, AK | $36K |
| Tanana Chiefs Conference, INC. | Fairbanks, AK | $26K |
| Tanana Chiefs Conference | Fairbanks, AK | $0.00 |
| Tanana Chiefs Conference | Fairbanks, AK | $0.00 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.